Advertisement

The Liver and Surgery

  • Jorge Daruich
  • Estela Manero
  • Alfredo Parietti

Abstract

Individuals with hemophilia frequently present with infections caused by the hepatitis C (HCV), hepatitis B (HBV), and human immunodeficiency (HIV) viruses. Therefore, the possible need for an anesthetic-surgical procedure must be analyzed carefully in order to determine the presence and severity of hepatic illness, as morbidity and mortality may be increased within this sick group.

Keywords

Portal Hypertension Anesthetic Agent Hepatic Blood Flow Alcoholic Hepatitis Constrictive Pericarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedman LS, Maddrey WC (1987) Surgery in the patients with the liver disease. Med Clin North Am 71:453–476PubMedGoogle Scholar
  2. 2.
    Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29:1617–1623PubMedCrossRefGoogle Scholar
  3. 3.
    Rosenberg PM, Friedman LS (2003) The liver in circulatory failure. In: Schiff ER, Sorell MF, Maddrey (eds) Diseases of the liver, 9th edition. Lippincott-Raven, Philadelphia, pp 1327–1340Google Scholar
  4. 4.
    Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74:593–600PubMedGoogle Scholar
  5. 5.
    Bruix J, Castells A, Bosch J et al (1996) Resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022PubMedCrossRefGoogle Scholar
  6. 6.
    Grace ND, Garcia-Pagan JC, Angelico M et al (2006) Primary prophilaxis for variceal bleeding. De In: Franchis R (ed). Proceedings of the 4th Baveno International Consensus Worshop on Portal Hypertension. Blackwell Publishing Ltd, Oxford, pp 168–200Google Scholar
  7. 7.
    Longnecker DE, Tinker JH, Morgan GE (1998) Principles and practice of anesthesiology, 2nd ed. Mosby, St LouisGoogle Scholar
  8. 8.
    Prys-Roberts C, Brown BR (1996) International practice of anaesthesia, Butterworth-Heinemann, OxfordGoogle Scholar
  9. 9.
    Cárdenas A, Ginés P, Rodés J (2003) Renal complications and hepatorenal syndrome. In: Schiff ER, Sorell MF, Maddrey (eds) Diseases of the liver, 9th edition. Lippincott-Raven, Philadelphia, pp 497–512Google Scholar
  10. 10.
    Conn HO (1981) A peek at the Child-Turcotte classification. Hepatology 1:673–676PubMedCrossRefGoogle Scholar
  11. 11.
    Morgan GE, Mikhail MS (1999) Anestesiología clínica. El Manual Moderno, MéxicoGoogle Scholar
  12. 12.
    Córdoba J, Mínguez B (2008) Hepatic encephlopathy. Semin Liver Dis 28:70–80PubMedCrossRefGoogle Scholar
  13. 13.
    Dawidowicz AL, Fornal E, Mardarowicz M, Fijalkowska A (2000) The role of human lungs in the biotransformation of propofol. Anesthesiology 93:992–997PubMedCrossRefGoogle Scholar
  14. 14.
    Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–851PubMedCrossRefGoogle Scholar
  15. 15.
    Iwanaga Y, Komatsu H, Yokono S, Ogli K (2000) Serum glutathione S-transferase alpha as a measure of hepatocellular function following prolonged anaesthesia with sevoflurane and halothane in paediatric patients. Paediatric Anaesthesia 10:95–98CrossRefGoogle Scholar
  16. 16.
    Inoda Y, Kharasch ED (2001) Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 95:509–514CrossRefGoogle Scholar
  17. 17.
    Chen TL, Wu CH, Chen TG et al (2000) Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems. Br J Anaesth 84:771–776PubMedGoogle Scholar
  18. 18.
    Darling JR, Sharpe PC, Stiby EK et al (2000) Serum mitochondrial aspartate transaminase activity after isoflurane or halothane anaesthesia. Br J Anaesth 85:195–198PubMedCrossRefGoogle Scholar
  19. 19.
    Zimmerman HJ (1999) Anesthesic agents. In: Zimmerman HJ (ed) Hepatotoxicity: the adverse effcects of drugs and other chemicals on the liver, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, pp 457–482Google Scholar
  20. 20.
    Zimmerman HJ (1999) Classification of hepatotoxins and mechanims of toxicity. In: Zimmerman HJ (ed) Hepatotoxicity: the adverse effcects of drugs and other chemicals on the liver, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, pp 111–145Google Scholar
  21. 21.
    Bruun LS, Elkjaer S, Bitsch-Larsen D, Andersen O (2001) Hepatic failure in a child after acetaminophen and sevoflurane exposure. Anesthes Analg 92:1446–1448CrossRefGoogle Scholar
  22. 22.
    Nishiyama T, Yokoyama T, Hanaoka K (1998) Liver and renal function after repeated sevoflurane or isoflurane anaesthesia. Can J Anaesth 45:789–793PubMedGoogle Scholar
  23. 23.
    Obata R, Bito H, Ohmura M et al (2000) The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function. Anesth Analg 91:1262–1268PubMedCrossRefGoogle Scholar
  24. 24.
    Dumont L, Picard V, Marti RA, Tassonyi E (1998) Use of remifentanil in a patient with chronic hepatic failure. Br J Anaesth 81:265–267PubMedGoogle Scholar
  25. 25.
    Navapurkar VU, Archer S, Gupta SK et al (1998) Metabolism of remifentanil during liver transplantation. Br J Anaesth 81:881–886PubMedGoogle Scholar
  26. 26.
    Zimmerman HJ (1999) Drugs used to treat rheumatic and musculopatic disease. In: Zimmerman HJ (ed) Hepatotoxicity: the adverse effcects of drugs and other chemicals on the liver, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, pp 517–554Google Scholar
  27. 27.
    Zimmerman HJ (1999) Psychotropic and anticonvulsivant agents. In: Zimmerman HJ (ed) Hepatotoxicity: the adverse effcects of drugs and other chemicals on the liver, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, pp 483–516Google Scholar
  28. 28.
    Court MH, Duan SX, Hesse LM et al (2001) Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 94:110–119PubMedCrossRefGoogle Scholar
  29. 29.
    Ebert TJ, Arain SR (2000) Renal responses to low-flow desflurane, sevoflurane, and propofol in patients. Anesthesiology 93:1401–1406PubMedCrossRefGoogle Scholar
  30. 30.
    Friederich P, Benzenberg D, Trellakis S et al (2001) Interaction of volatile anesthetics with human Kv channels in relation to clinical concentrations. Anesthesiology 95:954–958PubMedCrossRefGoogle Scholar
  31. 31.
    Guitton J, Buronfosse T, Desage M et al (1998) Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth 80:788–795PubMedGoogle Scholar
  32. 32.
    Osawa M, Shinomura T (1998) Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia. Can J Anaesth 45:1215–1218PubMedCrossRefGoogle Scholar
  33. 33.
    Hamaoka N, Oda Y, Hase I, Asada A (2001) Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. Br J Anaesth 86:540–544PubMedCrossRefGoogle Scholar
  34. 34.
    Green DW, Fisher M, Sockalingham I (1998) Mivacurium compared with succinylcholine in children with liver disease. Br J Anaesth 81:463–465PubMedGoogle Scholar
  35. 35.
    Fisher DM, Dempsey GA, Atherton DP et al (2000) Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion. Anesthesiology 93:1384–1391PubMedCrossRefGoogle Scholar
  36. 36.
    Duvaldestin P, Slavov V, Rebufat Y (1999) Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis. Anesthesiology 91:1305–1310PubMedCrossRefGoogle Scholar
  37. 37.
    Proost JH, Eriksson LI, Mirakhur RK et al (2000) Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth 85:717–723PubMedCrossRefGoogle Scholar
  38. 38.
    Proost JH, Eriksson LI, Mirakhur RK et al (2000) Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth 85:717–723PubMedCrossRefGoogle Scholar
  39. 39.
    Ziser A, Plevak DJ, Wiesner RH et al (1999) Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90:42–53PubMedCrossRefGoogle Scholar
  40. 40.
    Yokoyama M, Ohashi I, Nakatsuka H et al (2001) Drug-induced liver disease during continuous epidural block with bupivacaine. Anesthesiology 95:259–261PubMedCrossRefGoogle Scholar
  41. 41.
    Power LM, Thackray NM (1999) Reduction of preoperative investigations with the introduction of an anaesthetist-led preoperative assessment clinic. Anaesth Intens Care 27:481–488Google Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Jorge Daruich
    • 1
  • Estela Manero
    • 1
  • Alfredo Parietti
    • 2
  1. 1.Liver Section of Clínicas San Martín Hospital, School of Liver MedicineBuenos Aires UniversityBuenos, AiresArgentina
  2. 2.Anesthesiology Area of the Therapeutical and Diagnostical Gastroenterology CentreBuenos AiresArgentina

Personalised recommendations